Pre-mixed, ready-to-use iv bolus compositions and methods of use

Details for Australian Patent Application No. 2007237903 (hide)

Owner PDL BioPharma, Inc.

Inventors Gupta, Supriya; Mi, Yanli; Zamiri, Camellia

Agent Spruson & Ferguson

Pub. Number AU-A-2007237903

PCT Pub. Number WO2007/121483

Priority 60/793,074 18.04.06 US

Filing date 18 April 2007

Wipo publication date 25 October 2007

International Classifications

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/121483 Priority application(s): WO2007/121483

8 January 2009 Alteration of Name

  The name of the applicant has been altered to EKR Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007237904-6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling

2007237901-Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors